Using MRI to Grade Breast Cancer and Predict Outcome
Part of Cancer, Skin clinical trials.
This study uses advanced MRI scans to better understand breast cancer grade and outlook. It aims to see if computer analysis of MRI images can help predict tumor behavior, which could guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with breast cancer through a biopsy or surgery.
- You need to have had a special MRI scan (DCE-MRI) within two weeks before starting any treatment.
- You must not have received any cancer treatment (like chemotherapy, radiation, or hormone therapy) before that MRI.
- Your tumor must be larger than 5 millimeters (about the size of a pencil eraser).
- Your MRI images must be clear, without blurring or missing information.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests advanced MRI imaging techniques to better diagnose breast cancer and evaluate treatment response. If you have a suspicious breast lesion, this trial may help doctors see it more clearly before biopsy or surgery.
This trial compares a special mammogram with dye (CEDM) to MRI for women already diagnosed with invasive breast cancer. The goal is to see if CEDM works as well as MRI for planning surgery, potentially offering a faster or easier option.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
This study uses breast MRI scans to see whether neoadjuvant (before-surgery) chemotherapy is working. If you qualify, you’ll have MRI scans to help doctors understand how your breast cancer responds to standard treatment.
This study uses a special type of mammogram with contrast dye to see if it can predict how well breast cancer responds to chemotherapy before surgery. It's for people with HER2-positive or triple-negative breast cancer.
This study uses a special type of MRI called diffusion-weighted imaging to help diagnose breast cancer and check on it after treatment. It is for women who have a breast lump or whose breast cancer has returned after chemotherapy or radiation.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.